Cargando…
Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura
INTRODUCTION: Severe acute kidney injury (AKI) and chronic kidney disease (CKD) are considered to be uncommon in patients with acquired thrombotic thrombocytopenic purpura. However, a recent case series from a tertiary care hospital indicated that 54 (59%) of 92 patients with thrombotic thrombocytop...
Autores principales: | Little, Dustin J., Mathias, Lauren M., Page, Evaren E., Kremer Hovinga, Johanna A., Vesely, Sara K., George, James N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733749/ https://www.ncbi.nlm.nih.gov/pubmed/29270517 http://dx.doi.org/10.1016/j.ekir.2017.06.007 |
Ejemplares similares
-
Hypertension in patients with hereditary thrombotic thrombocytopenic purpura
por: Borogovac, Azra, et al.
Publicado: (2020) -
Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022) -
Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura
por: Edgar, Contessa E., et al.
Publicado: (2015) -
Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study
por: Knoebl, Paul, et al.
Publicado: (2019) -
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)